TUMOR BLOOD TESTING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Tumor Blood Testing Market, By Biomarker Type (Circulating Tumor DNA (ctDNA), Circulating Tumor Cells (CTCs), Extracellular Vehicles (EVs)/Exosomes, and Other Cell-Free Nucleic Acids), By Technology (Polymerase Chain Reaction (PCR)-Based Testing, Next-Generation Sequencing (NGS), Microarray-Based Testing, Mass Spectrometry, and Immunoassays), By Clinical Application (Early Detection/Cancer Screening, Diagnosis, Therapy Selection, Treatment Monitoring, Minimal Residual Disease (MRD) Detection, and Recurrence Monitoring/Prognosis), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer , Bladder Cancer, Melanoma, and Other Cancers (e.g., Ovarian, Pancreatic, Leukemia, Lymphoma)), By End User (Hospitals, Specialty Clinics, Diagnostic Laboratories, Academic and Research Institutes, and Pharmaceutical and Biotechnology Companies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Published In: 30 Mar, 2026
Code: CMI8830
Page number: 168
Formats: Excel and PDF
Industry: Clinical Diagnostic
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Global Tumor Blood Testing Market, By Biomarker Type
  - Global Tumor Blood Testing Market, By Technology
  - Global Tumor Blood Testing Market, By Clinical Application
  - Global Tumor Blood Testing Market, By Cancer Type
  - Global Tumor Blood Testing Market, By End User
  - Global Tumor Blood Testing Market, By Region
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- Industry Trends
Global Tumor Blood Testing Market, By Biomarker Type, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Circulating Tumor DNA (ctDNA)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Circulating Tumor Cells (CTCs)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Extracellular Vesicles (EVs) / Exosomes
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Cell-Free Nucleic Acids
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Tumor Blood Testing Market, By Technology, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Polymerase Chain Reaction (PCR)-Based Testing
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Next-Generation Sequencing (NGS)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Microarray-Based Testing
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Mass Spectrometry
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Immunoassays
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Tumor Blood Testing Market, By Clinical Application, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Early Detection/Cancer Screening
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnosis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Therapy Selection
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Treatment Monitoring
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Minimal Residual Disease (MRD) Detection
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Recurrence Monitoring/Prognosis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Tumor Blood Testing Market, By Cancer Type, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Lung Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Breast Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Colorectal Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Prostate Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Bladder Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Melanoma
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Cancers (e.g., Ovarian, Pancreatic, Leukemia, Lymphoma)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Tumor Blood Testing Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Hospitals
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Specialty Clinics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic Laboratories
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Academic and Research Institutes
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pharmaceutical and Biotechnology Companies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Tumor Blood Testing Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
  - Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
  - Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Clinical Application, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Cancer Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Clinical Application, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Cancer Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Clinical Application, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Cancer Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Clinical Application, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Cancer Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Clinical Application, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Cancer Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Clinical Application, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Cancer Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- Hoffmann-La Roche Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Illumina, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Guardant Health
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bio-Rad Laboratories
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Abbott Laboratories
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Qiagen
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Agilent Technologies
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Thermo Fisher Scientific
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Siemens Healthineers
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- GE Healthcare
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- BD (Becton, Dickinson and Company)
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- PerkinElmer
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Myriad Genetics
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Sysmex Corporation
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Danaher Corporation
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us

*Browse 32 market data tables and 28 figures on ‘Tumor Blood Testing Market' - Global forecast to 2033

Instant Download - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now